George Simeon
CIK: 0001595117
Director10% Owner
Primary company: CRISPR Therapeutics AG (CRSP)
George Simeon is a corporate insider at CRISPR Therapeutics AG (CRSP) filing SEC Form 4 transactions. 84 transactions across 6 companies, totaling $130,170,212 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AG CRSP | Exercise | 30,000 | $14.00 | $420K | 0 | 10/14/2026 Filed: 10/14/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Sale | 14,514 | $49.63 | $720K | 15,486 | 10/14/2026 Filed: 10/14/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Exercise | 30,000 | $14.00 | $420K | 30,000 | 10/14/2026 Filed: 10/14/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 169,001 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,667,468 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,538,691 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 512,897 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,113,666 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 3,334,938 | - | - | 0 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Purchase | 592,593 | $17.00 | $10.07M | 592,593 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 169,001 | - | - | 1,836,469 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,667,468 | - | - | 1,667,468 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Purchase | 414,814 | $17.00 | $7.05M | 1,953,505 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,538,691 | - | - | 1,538,691 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Purchase | 592,593 | $17.00 | $10.07M | 5,554,094 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 512,897 | - | - | 4,961,501 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 1,113,666 | - | - | 4,448,604 | 9/28/2026 Filed: 9/28/2026 | Filing → |
ADARx Pharmaceuticals, Inc. ADRX | Conversion | 3,334,938 | - | - | 3,334,938 | 9/28/2026 Filed: 9/28/2026 | Filing → |
Nkarta, Inc. NKTX | Award | 37,000 | $2.46 | $91K | 37,000 | 6/10/2026 Filed: 6/10/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 13,000 | $51.84 | $674K | 13,000 | 6/5/2026 Filed: 6/5/2026 | Filing → |
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
30,000
Price
$14.00
Value
$420K
CRISPR Therapeutics AG
CRSP
Type
Sale
Shares
14,514
Price
$49.63
Value
$720K
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
30,000
Price
$14.00
Value
$420K
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
169,001
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,667,468
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,538,691
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
512,897
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,113,666
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
3,334,938
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Purchase
Shares
592,593
Price
$17.00
Value
$10.07M
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
169,001
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,667,468
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Purchase
Shares
414,814
Price
$17.00
Value
$7.05M
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,538,691
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Purchase
Shares
592,593
Price
$17.00
Value
$10.07M
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
512,897
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
1,113,666
Price
-
Value
-
ADARx Pharmaceuticals, Inc.
ADRX
Type
Conversion
Shares
3,334,938
Price
-
Value
-
Nkarta, Inc.
NKTX
Type
Award
Shares
37,000
Price
$2.46
Value
$91K
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
13,000
Price
$51.84
Value
$674K
AI Agent
Try asking...